Table 6.
Summary of KEGG pathway, miRNA, and GO analysis.
| KEGG Pathway | p-Value | Adjusted p-Value |
| Fatty acid metabolism | 1.64 × 10−3 | 2.00 × 10−3 |
| Oxidative phosphorylation | 1.49 × 10−3 | 2.00 × 10−3 |
| Valine, leucine and isoleucine degradation | 1.61 × 10−3 | 2.00 × 10−3 |
| Arachidonic acid metabolism | 1.69 × 10−3 | 2.00 × 10−3 |
| Pyruvate metabolism | 1.64 × 10−3 | 2.00 × 10−3 |
| KEGG miRNA | p-Value | Adjusted p-Value |
| miR-501_AAAGGAT | 1.45 × 10−3 | 0.319 |
| miR-26a/miR-26b_TACTTGA | 8.44 × 10−3 | 0.481 |
| miR-507_GTGCAAA | 8.71 × 10−3 | 0.481 |
| miR-33_CAATGCA | 6.05 × 10−3 | 0.481 |
| miR-200b/miR-200c/miR-429_CAGTATT | 2.03 × 10−2 | 0.660 |
| GO Analysis | p-Value | Adjusted p-Value |
| Spinal cord development | 1.61 × 10−3 | 5.97 × 10−2 |
| Neuromuscular junction development | 1.64 × 10−3 | 5.97 × 10−2 |
| Cytoplasmic translation | 3.08 × 10−3 | 5.97 × 10−2 |
| Positive regulation of calcium ion transport | 2.87 × 10−3 | 5.97 × 10−2 |
| Regulation of antigen receptor mediated signaling pathway | 2.62 × 10−3 | 5.97 × 10−2 |